Marshall Wace’s TuHURA Biosciences HURA Stock Holding History

Marshall Wace’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-35,571	Closed	-$79.3K	–	3519
2025 Q2	$79.3K	Buy	+35,571	New	+$120K	﹤0.01%	2564

Other funds holding HURA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Marshall Wace's HURA Position: Q3 2025 in Review

Marshall Wace sold out of TuHURA Biosciences (HURA) in Q3 2025, closing a stake of 35,571 shares — an estimated $79.3K sold.

Marshall Wace first reported a position in HURA in Q2 2025 and held it in 1 quarter. The position peaked at $79.3K in Q2 2025. 70 funds tracked by Wall St. Rank hold HURA as of Q3 2025.

Marshall Wace reported no remaining TuHURA Biosciences position as of Q3 2025 after selling out during the quarter.
Marshall Wace sold 35,571 TuHURA Biosciences shares in Q3 2025, an estimated $79.3K.
Marshall Wace first reported a position in TuHURA Biosciences in Q2 2025 and held it in 1 quarter.
Marshall Wace's TuHURA Biosciences position peaked at $79.3K in Q2 2025.
70 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.